Results · Apr-Jun 2026 · filed 6 Aug 2026
Fortis Healthcare Q1 FY27 results
Sales grew 17% to ₹2,545 crore from ₹2,167 crore in Apr-Jun 2025.
Operating profit grew 9% to ₹537 crore, an operating margin of 21.1% (down 1.5 points from a year ago).
Net profit grew 2% to ₹273 crore from ₹267 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +8%, net profit +1%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 2,545 | 2,167 | +17% |
| Operating profit (EBITDA) | 537.1 | 490.7 | +9% |
| Operating margin | 21.1% | 22.6% | −1.5 pts |
| Net profit | 272.8 | 266.8 | +2% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Fortis Healthcare held a call to address a Delhi High Court order directing a forensic audit into share transactions & the company's 2018 dealings with IHH. Management stated the audit does not impede operational or strategic plans & they expect the 6-month forensic process to conclude the litigation.
The last 7 quarters
Filings that week
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 11 Aug 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 11 Aug 2026Summary Of The Proceedings Of The 30Th Annual General Meeting.
- 11 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.